Cancer. A bull's eye for targeted lung cancer therapy
- PMID: 15178790
- DOI: 10.1126/science.1099578
Cancer. A bull's eye for targeted lung cancer therapy
Comment on
-
EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.Science. 2004 Jun 4;304(5676):1497-500. doi: 10.1126/science.1099314. Epub 2004 Apr 29. Science. 2004. PMID: 15118125
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical